CDT Insider Filing: 35,000 RSUs Vest; 15,000 Options Granted at $1.89
Rhea-AI Filing Summary
Freda C. Lewis-Hall, a director of CDT Equity Inc. (CDT), reported equity awards and holdings. On 08/12/2025 she received 35,000 restricted stock units (RSUs) in exchange for past services; the RSUs vested immediately and were valued at approximately $60,900 based on the 08/12/2025 closing price. The earliest transaction date reported is 08/05/2025, when she was granted 15,000 stock options under the 2023 Stock Incentive Plan at an exercise price of $1.89; those options vested immediately, are exercisable as of 08/05/2025 and expire 08/05/2035. Following the RSU grant, Ms. Lewis-Hall directly beneficially owned 38,466 shares; she also discloses indirect holdings of 1,335 shares held by Intelmed LLC and 344 shares held by her spouse, which she disclaims except to the extent of any pecuniary interest. The Form 4 is signed by Ms. Lewis-Hall on 08/26/2025.
Positive
- 35,000 RSUs vested immediately, providing clear, disclosed compensation for past services
- 15,000 stock options vested immediately at a stated exercise price of $1.89 with a 2035 expiration, aligning incentives
- Complete disclosure of indirect holdings (Intelmed LLC and spouse) with explicit disclaimers
Negative
- None.
Insights
TL;DR: Routine equity compensation disclosed; modest share increase and immediate vesting of options and RSUs.
The filing documents non-cash compensation and immediate vesting: 35,000 RSUs issued on 08/12/2025 with an indicated value of about $60,900 and 15,000 options granted 08/05/2025 at a $1.89 exercise price that vest immediately and expire in 2035. The increase in directly held shares to 38,466 is primarily the result of the RSU grant. These are typical director/executive equity awards rather than market-moving transactions, and the disclosure is consistent with standard Form 4 reporting practices.
TL;DR: Disclosure reflects standard governance practice for director compensation and related-party holdings.
The report identifies Ms. Lewis-Hall as a director and discloses both direct and indirect holdings, including shares held by Intelmed LLC and by her spouse, with appropriate disclaimers. Immediate vesting of RSUs and options is clearly stated and the filing includes required provenance of awards. From a governance and disclosure standpoint, the Form 4 provides necessary transparency on beneficial ownership and potential related-party interests.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 35,000 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 15,000 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Represents restricted stock units ("RSUs") received on August 12, 2025, in exchange for past services, having a value equal to approximately $60,900 based on the closing price per share of the Issuer's common stock on August 12, 2025. The RSUs vest immediately upon grant. The shares are held of record by Intelmed LLC ("Intelmed"). Ms. Lewis-Hall is the Managing Director of Intelmed and in such capacity has voting and investment discretion with respect to the shares held of record by Intelmed. By virtue of this relationship, Ms. Lewis-Hall may be deemed to share beneficial ownership of the shares held of record by Intelmed. Ms. Lewis-Hall disclaims any such beneficial ownership except to the extent of her pecuniary interest therein. The shares are held by Ms. Lewis-Hall's spouse, Mr. Emerson Hall, Jr. As Mr. Hall's spouse and by virtue of their relationship, Ms. Lewis-Hall may be deemed to share beneficial ownership of such shares held by record by Mr. Emerson Hall, Jr. Ms. Lewis-Hall disclaims any such beneficial ownership except to the extent of her pecuniary interest therein. Represents options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan, which were granted at the conclusion of the Issuer's 2025 annual meeting of stockholders. The options vest immediately upon grant.
